AKT1 and B-cell chronic lymphocytic leukemia: Previously, we reported decreased expression of CD180 in the B cells of dcSSc patients [19], and CD180 was described to utilize the PI3K/Akt pathway in B-cell chronic lymphocytic leukemia (B-CLL) [20].